Bottom line
Is RYSBX a good fund? The bottom line
RYSBX is the Class H share class of Strengthening Dollar 2x Strategy Fund, a managed leveraged & inverse mutual fund from Guggenheim.
Its expense ratio is 1.93% — about $193 a year on every $10,000 invested, more expensive than 93% of leveraged & inverse funds we track.
It returned −14.1% over one year, +6.4% a year over five years, +1.9% a year over ten (as of Dec 31, 2025, per its prospectus).
With $2.3 million in net assets and 4 holdings, its largest position is J.p. Morgan Securities Llc (46.7%) and the top 10 make up 94.7% of the portfolio.
What stands out
- 5-year return beat 79% of category peers
What to watch
- Expensive for its category (1.93%)
- Concentrated: top 10 holdings are 94.7% of assets
- 12b-1 marketing fee of 0.25% a year
- Small fund ($2.3 million) — small funds are likelier to close
Updated Nov 19, 2026
What RYSBX invests in
The Fund seeks to provide investment results that match the performance of a specific benchmark, before fees and expenses, on a daily basis. The Funds current benchmark is 200% of the performance of the U.S. Dollar Index (the underlying index). The Fund does not seek to achieve its investment objective over a period of time greater than one day.
The Fund employs as its investment strategy a program of investing in derivative instruments, which primarily consist of index swaps, futures contracts, and options on securities, securities indices, and futures contracts. While the Fund may write (sell) and purchase swaps, it expects primarily to purchase swaps. The Advisor attempts to consistently apply leverage to increase the Fund's exposure to 200% of the underlying index, and expects to rebalance the Fund's holdings daily to maintain such exposure. Investing in derivative instruments enables the Fund to pursue its investment objective without investing directly in the securities included in the underlying index or in the same proportion that those securities are represented in the Fund's benchmark. The Funds use of derivatives and the leveraged investment exposure created by such use are expected to be significant. Certain of the…
From the fund's prospectus (filed Jul 29, 2026).
RYSBX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RYSBX | −14.1% | +6.4% | +1.9% |
| Leveraged & Inverse median | −7.7% | −11.8% | −13.5% |
Source: Fund prospectus, as of Dec 31, 2025
What RYSBX costs
On a $10,000 investment, RYSBX's 1.93% expense ratio costs about $193 a year. The prospectus estimates $2,351 in total costs over 10 years (assuming 5% annual returns). The median leveraged & inverse fund charges 1.31%.
RYSBX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | J.p. Morgan Securities Llc | 46.73% |
| 2 | Merrill Lynch, Pierce, Fenner & Smith Incorporated | 46.73% |
| 3 | Ice Futures U.s. | 0.89% |
| 4 | Goldman Sachs & Co. Llc | 0.36% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 94.7% of the fund. See all top 25 holdings and asset mix →